MENU
TLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TriSalus Life Sciences (TLSI) Ownership - Who owns TriSalus Life Sciences?

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors... Show more

Profile

Industry
N/A
Address
6272 W. 91st Avenue
Phone
+1 888 321-5212
Employees
102
Web
https://www.trisaluslifesci.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
225.98M
P/E Ratio
-2.76
Total Cash
46.29M
Projected Growth
N/A
Total Debt
34.43M
Revenue
45.08M
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash/Share
0.75
Total Debt/Equity
N/A
Revenue/Share
0.90 USD as % of share price
Who owns TriSalus Life Sciences? TLSI symbol Ownership - Tickeron.com